Kotha, Surya S.
Hayes, Brian J.
Phong, Kiet T.
Redd, Meredith A.
Bomsztyk, Karol
Ramakrishnan, Aravind
Torok-Storb, Beverly
Zheng, Ying
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1DP2DK102258-01, 3P30DK056465-16S1)
National Heart, Lung, and Blood Institute (5U01HL099993-07)
National Cancer Institute (5R33CA191135-03)
National Institute of General Medical Sciences (R21GM111439)
National Institute of Diabetes and Digestive and Kidney Diseases (NIH R01DK103849-02)
National Institute of Diabetes and Digestive and Kidney Diseases (3U54DK106829)
Article History
Received: 9 October 2017
Revised: 10 January 2018
Accepted: 19 February 2018
First Online: 23 March 2018
Ethics approval and consent to participate
: Healthy hematopoietic progenitor cells and patient-derived acute myeloid leukemia samples were obtained under protocols approved by the Fred Hutchinson Cancer Research Institute (Protocol 0999.209). Peripheral blood was obtained with written informed consent under protocols approved by the Fred Hutchinson Cancer Research Institute (Protocol 211:00).
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.